27. August 2014 | Hepatitis C

Hepatitis C drug daclatasvir approved by European regulators

Statement» MSF urges Bristol-Myers Squibb to ensure the drug is affordable in those countries with a high burden of hepatitis C.

Photo by Cristina De Middel